Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD40 anticorps

CD40 Reactivité: Souris, Rat FACS Hôte: Hamster arménien Monoclonal HM40 unconjugated
N° du produit ABIN2689247
  • Antigène Voir toutes CD40 Anticorps
    CD40
    Reactivité
    • 198
    • 113
    • 21
    • 20
    • 7
    • 6
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Souris, Rat
    Hôte
    • 113
    • 100
    • 55
    • 6
    • 1
    • 1
    • 1
    • 1
    Hamster arménien
    Clonalité
    • 182
    • 89
    • 5
    Monoclonal
    Conjugué
    • 124
    • 26
    • 22
    • 21
    • 14
    • 8
    • 7
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CD40 est non-conjugé
    Application
    • 157
    • 97
    • 64
    • 54
    • 32
    • 32
    • 20
    • 19
    • 17
    • 14
    • 13
    • 13
    • 8
    • 6
    • 5
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS)
    Marque
    BD Pharmingen™
    Attributs du produit
    The HM40-3 antibody reacts with CD40, a 40-50- kDa glycoprotein expressed on B lymphocytes and other antigen-presenting cells. The CD40 Molecule has a central role in B-cell growth and differentiation. Furthermore, interactions of CD40 with its ligand, CD154, are involved in the initiation and effector stages of cell-mediated immune responses. CD40 may be involved in the triggering of NK cells and NK-T cells. Soluble HM40-3 antibody stimulates splenic and peritoneal B cells to proliferate in vitro. This antibody also induces spleen B cells to express the costimulatory molecules CD80 (B7-1) and CD86 (B7-2). HM40-3 mAb has been demonstrated to inhibit the binding of soluble CD154 (gp39, CD40 Ligand) to soluble CD40 and to cell-surface CD40. This hamster mAb to a mouse leukocyte antigen has been observed to cross-react with similar populations of Lewis, Sprague-Dawley, and LOU16 rat leukocytes. Two-color analysis of the expression of CD40 on mouse spleen cells. BALB/c mouse splenocytes were simultaneously stained with PE Rat Anti-Mouse CD45R/B220 mAb (Cat. No. 553089/553090, both panels) and either Purified Hamster Anti-Mouse CD40 mAb (Cat. No. 553722, Right Panel) or Purified Hamster IgM, λ1 Isotype Standard (Cat. No 553958, Left Panel) followed by FITC Mouse Anti-Armenian Hamster IgM mAb (Cat. No. 554033, both panels). Flow cytometry was performed on a BD FACScan™ flow cytometry system.

    BD Pharmingen™ Purified Hamster Anti-Mouse CD40 - Purified - Clone HM40-3 - Isotype Armenian Hamster IgM, κ - Reactivity Ms, Rat - 0.1 mg
    Purification
    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
    Immunogène
    (BALB/c x NZB) F1 Mouse-derived Lymphoma WEHI-231
    Clone
    HM40
    Isotype
    IgM kappa
    Top Product
    Discover our top product CD40 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Concentration
    0.5 mg/mL
    Buffer
    Aqueous buffered solution containing protein stabilizer and ≤0.09 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
    Stockage commentaire
    Store undiluted at 4°C.
  • Turner, Rakhmilevich, Burdelya, Neal, Imboden, Sondel, Yu: "Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 166, Issue 1, pp. 89-94, (2001) (PubMed).

    Trinité, Voisine, Yagita, Josien: "A subset of cytolytic dendritic cells in rat." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 165, Issue 8, pp. 4202-8, (2000) (PubMed).

    Akiba, Oshima, Takeda, Atsuta, Nakano, Nakajima, Nohara, Yagita, Okumura: "CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 162, Issue 12, pp. 7058-66, (1999) (PubMed).

    Leifeld, Trautwein, Dumoulin, Manns, Sauerbruch, Spengler: "Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure." dans: The American journal of pathology, Vol. 154, Issue 6, pp. 1711-20, (1999) (PubMed).

    Tomura, Yu, Ahn, Yamashita, Yang, Ono, Hamaoka, Kawano, Taniguchi, Koezuka, Fujiwara: "A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 163, Issue 1, pp. 93-101, (1999) (PubMed).

    Grewal, Flavell: "CD40 and CD154 in cell-mediated immunity." dans: Annual review of immunology, Vol. 16, pp. 111-35, (1998) (PubMed).

    Ridge, Di Rosa, Matzinger: "A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell." dans: Nature, Vol. 393, Issue 6684, pp. 474-8, (1998) (PubMed).

    Kaneko, Hirose, Abe, Yagita, Okumura, Shirai: "CD40-mediated stimulation of B1 and B2 cells: implication in autoantibody production in murine lupus." dans: European journal of immunology, Vol. 26, Issue 12, pp. 3061-5, (1997) (PubMed).

    Kawano, Cui, Koezuka, Toura, Kaneko, Motoki, Ueno, Nakagawa, Sato, Kondo, Koseki, Taniguchi: "CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides." dans: Science (New York, N.Y.), Vol. 278, Issue 5343, pp. 1626-9, (1997) (PubMed).

    Kashiwada, Kaneko, Yagita, Okumura, Takemori: "Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells." dans: European journal of immunology, Vol. 26, Issue 7, pp. 1451-8, (1996) (PubMed).

    Inaba, Inaba, Fukuba, Mori, Haruna, Doi, Adachi, Iwai, Hosaka, Hisha: "Activation of thymic B cells by signals of CD40 molecules plus interleukin-10." dans: European journal of immunology, Vol. 25, Issue 5, pp. 1244-8, (1995) (PubMed).

    Foy, Laman, Ledbetter, Aruffo, Claassen, Noelle: "gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory." dans: The Journal of experimental medicine, Vol. 180, Issue 1, pp. 157-63, (1994) (PubMed).

    Inaba, Witmer-Pack, Inaba, Hathcock, Sakuta, Azuma, Yagita, Okumura, Linsley, Ikehara, Muramatsu, Hodes, Steinman: "The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro." dans: The Journal of experimental medicine, Vol. 180, Issue 5, pp. 1849-60, (1994) (PubMed).

    Parry, Hasbold, Holman, Klaus: "Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 152, Issue 6, pp. 2821-9, (1994) (PubMed).

    Noelle, Ledbetter, Aruffo: "CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation." dans: Immunology today, Vol. 13, Issue 11, pp. 431-3, (1993) (PubMed).

  • Antigène
    CD40
    Autre désignation
    CD40 (CD40 Produits)
    Synonymes
    anticorps Bp50, anticorps CDW40, anticorps TNFRSF5, anticorps p50, anticorps AI326936, anticorps GP39, anticorps HIGM1, anticorps IGM, anticorps IMD3, anticorps T-BAM, anticorps TRAP, anticorps Tnfrsf5, anticorps TNFSF5, anticorps CD40 molecule, anticorps CD40 antigen, anticorps CD40, anticorps Cd40
    Sujet
    Synonyms: Bp50, Tnfrsf5, TNR5, TRAP, CD40L receptor, GP39, HIGM1, IMD3, T-BAM
    Pathways
    Signalisation NF-kappaB, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Vous êtes ici:
Support technique